Online Survey · 2026

What the Antibody + TIDES audience wants from webinars in 2026

What works, what doesn't, and what's next — straight from the scientists and industry leaders across Antibody Engineering & Therapeutics and TIDES Oligonucleotide & Peptide Therapeutics who actually attend them.

Scroll the findings
The headline numbers

Webinars are still earning attention.

Despite a crowded content landscape, the Antibody + TIDES audience treats webinars as the most valuable B2B format for professional learning.

0%
Attended at least one webinar in 2025
A decisive majority of respondents
0
Webinars per year
Typical attendance across the Antibody + TIDES audience
0%
Prefer webinars over podcasts
When the content is identical — across every generation
0 min
Preferred webinar length
48% prefer 20–30 minute formats
Why they register

Role-relevance and learning drive sign-ups.

The top two registration drivers are a clear connection between the topic and the attendee's role, and the opportunity to learn something new.

Mission critical: when content speaks directly to a role, 79% of attendees stay through the end.
Topic clearly relevant to my role69%
Opportunity to learn something new66%
Exclusive data, research, or insights48%
Recognized speakers / experts35%
On-demand access22%
Relevance = retention

Attention is earned — and easily lost.

With literally zero respondents saying they always stay through to the end, sticking with a session is a vote for relevance, not loyalty.

0%
Stay through the end
When the topic is highly relevant to their role
0%
Leave early
When content doesn't meet expectations on relevance
0%
Are willing to drop off
No one said they always stay to the end — retention is earned every minute
What audiences want

Insight-led. Evidence-based. Expert-delivered.

The winning formula for the Antibody + TIDES audience blends real-world case studies with rigorous data, fronted by presenters they trust.

75%
Research-based insights
The most engaging content type
60%
Professional associations / universities
Preferred webinar hosts
59%
Industry trends & forecasts
Where the market is heading
44%
Case studies & success stories
Real examples beat theory
Most valuable formats

Webinars top the B2B content stack.

The Antibody + TIDES audience rates webinars the most valuable format for professional and educational content — ahead of reports, articles, and social. Depth and credibility consistently outperform convenience-first channels.

Format% Very or extremely valuable
  • Webinars (live or on-demand)
    71%
  • Industry reports / whitepapers
    63%
  • Articles / features
    62%
  • LinkedIn
    48%
  • YouTube videos
    40%
  • Newsletters
    34%
  • Podcasts
    27%

Question: How valuable do you find the following formats for accessing B2B professional / educational content? Base: All respondents (n=81).

Preferred webinar formats

No single format wins — program a mix.

The Antibody + TIDES audience is split on how they want to engage. Keynotes and short-form mini-series lead in a near-tie, with product demos, panels, and workshops close behind. One format won't cover everyone.

Format% Preferred
  • Keynotes / thought leadership talks
    52%
  • Short-form or on-demand mini-series
    51%
  • Product demonstrations / tutorials
    31%
  • Panels or roundtable discussions
    29%
  • Interactive workshops
    26%

Question: Which webinar formats do you prefer? Select all that apply. Base: Respondents attending at least one webinar in the past year (n=65).

Format & timing

Shorter, tighter, on their terms.

Busy professionals want value without surrendering an hour. Flexible access turns a 'maybe' into a download.

0
avg. minutes preferred
35 minutes is the sweet spot

Attendees prefer an average of 35 minutes — and 48% specifically want 20–30 minute formats. Lack of time is a primary barrier to attendance.

0%
of live registrants may not attend live

Most hope to attend, but competing priorities take over — only 22% firmly plan to be there live. On-demand isn't a fallback; it's the access pattern.

Post-event assets aren't optional anymore

Slides, recordings, and related materials are now expected — for personal reference and to share with colleagues. They extend the perceived value long after the session ends.

Engagement playbook

How to keep them — and how to lose them.

Two short lists every program owner, host, and producer should pin above their desk.

DO

Engage them

  • 1Anchor topics clearly to audience roles and needs
  • 2Deliver practical, actionable takeaways early and often
  • 3Use credible presenters with engaging delivery style
  • 4Maintain strong pacing, structure and clear outcomes
  • 5Support content with concrete examples
DO NOT

Alienate them

  • 1Miss on content relevance or overpromise in promotions
  • 2Lead with sales messaging or product promotion
  • 3Let sessions drag or feel unfocused
  • 4Cover overly basic, general content
  • 5Assume audiences will “stick it out”
The 2026 mandate

Five things to commit to this year.

The opportunity mandate distilled from what the Life Sciences audience actually told us.

  1. 01

    Be audience-relevant before they register

    Position the topic, audience and outcome clearly on the registration page. No bait-and-switch.

  2. 02

    Be data-driven and scientifically rigorous

    Lead with results, real-world case studies, and regulatory context. Minimize promotional content.

  3. 03

    Keep it short and disciplined

    Around 30 minutes, focused and tightly structured. 35 minutes is the average preference, not the ceiling.

  4. 04

    Be credible and practitioner-led

    Prioritize scientific and technical experts. Vet speakers for communication skill, not just credentials.

  5. 05

    Deliver flexible access and follow-up

    On-demand recordings, slides and post-event assets are mission critical to perceived webinar value.

What to talk about

The topics Antibody + TIDES wants in 2026.

Technically deep, tutorial-driven, case-study-based, and honest about tradeoffs — content that helps attendees make better scientific, strategic, and operational decisions.

Next-Generation Biologic Modalities & Therapeutic Frontiers
AI in Biologics R&D: From Discovery to Developability
Deep-Dive Techniques, Assays & Translational Science
CMC, Manufacturing & Process Intensification
Regulatory Science, Policy & Compliance Strategy
Industry Trends, Investment & Strategic Decision-Making
Vendor Solutions, Case Studies & Applied Technology
Leadership, Talent & the Human Side of Biotech

Trusted by past webinar sponsors

Industry leaders who've reached Informa's Antibody & TIDES audiences through webinars.

4basebio logo
Agilent Technologies logo
Asymchem logo
Bruker logo
Cytiva logo
Kinovate Life Sciences logo
Primrose Bio logo
Waters Corporation logo
WuXi TIDES logo
PARTNER WITH INFORMA LIFE SCIENCES

Reach qualified TIDES & Antibody decision makers.

Put your brand in front of the R&D leaders, scientists, and executives who attend Informa's Antibody Engineering & Therapeutics and TIDES Oligonucleotide & Peptide Therapeutics webinars and conferences.